IP Library › Granted Patent US 11,447,770
Granted Patent B1
US 11,447,770 · App. 17/219,672 · Granted Sep 20, 2022

Methods and compositions for prime editing nucleotide sequences

Inventors: David R. Liu (Cambridge, MA); Andrew Vito Anzalone (Cambridge, MA); Gregory Newby (Cambridge, MA); Kelcee Everette (Cambridge, MA)
Assignees: The Broad Institute, Inc.; President and Fellows of Harvard College
C12N15/11C12N9/1276C12N9/22C12N15/907C12Y207/07049C07K2319/00C12N2310/20C12N2310/3519
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,447,770
App. No.
17/219,672
Granted
Sep 20, 2022
Kind
B1
Abstract

Compositions and methods are provided herein for conducting prime editing of a target DNA molecule (e.g., a genome) that enables the incorporation of a nucleotide change and/or targeted mutagenesis. The compositions include fusion proteins comprising nucleic acid programmable DNA binding proteins (napDNAbp) and a polymerase (e.g., reverse transcriptase), which is guided to a specific DNA sequence by a modified guide RNA, named a PEgRNA. The PEgRNA has been altered (relative to a standard guide RNA) to comprise an extended portion that provides a DNA synthesis template sequence which encodes a single strand DNA flap which is synthesized by the polymerase of the fusion protein and which becomes incorporated into the target DNA molecule.

Claims (41)

1. A method for site-specific modification of a double-stranded target DNA sequence, the method comprising:

contacting the double-stranded target DNA sequence, which comprises a first strand and a second strand, with a prime editing system, wherein the prime editing system comprises:

(i) a fusion protein comprising a nucleic acid programmable DNA binding protein (napDNAbp) and a reverse transcriptase, wherein the napDNAbp is a Cas9 nickase, a Cas12a nickase, or a Cas12b1 nickase, and

(ii) a prime editing guide RNA (PEgRNA) comprising:

(a) a spacer sequence that comprises a region of complementarity to the first strand of the double-stranded target DNA sequence;

(b) an extension arm that comprises a DNA synthesis template and a primer binding site in a 5′ to 3′ orientation, wherein the primer binding site comprises a region of complementarity to a region upstream of a nick site in the second strand of the double-stranded target DNA sequence, and wherein the DNA synthesis template encodes one or more nucleotide changes compared to a region downstream of the nick site in the second strand of the double-stranded target DNA sequence, and

(c) a gRNA core that interacts with the napDNAbp;

wherein the contacting results in:

nicking the second strand of the double-stranded target DNA sequence to form a free 3′ end at the nick site;

annealing the primer binding site with the region of the second strand of the double-stranded target DNA sequence upstream of the nick site;

synthesizing a single strand of DNA encoded by the DNA synthesis template from the free 3′ end of the second strand of the double-stranded target DNA sequence; and

replacing the region downstream of the nick site in the second strand of the double-stranded target DNA sequence with the single strand of DNA, thereby modifying the sequence of the double-stranded target DNA sequence.

2. The method of claim 1 , wherein the one or more nucleotide changes are 1-150 bases downstream of the nick site on the second strand.

3. The method of claim 1 , wherein the DNA synthesis template comprises a region of complementarity to the second strand of the double-stranded target DNA sequence.

4. The method of claim 1 , wherein the one or more nucleotide changes comprise a nucleotide substitution as compared to the region of the second strand downstream of the nick site in the double-stranded target DNA sequence.

5. The method of claim 1 , wherein the one or more nucleotide changes comprise a nucleotide deletion as compared to the region of the second strand downstream of the nick site in the double-stranded target DNA sequence.

6. The method of claim 1 , wherein the one or more nucleotide changes comprise a nucleotide insertion as compared to the region of the second strand downstream of the nick site in the double-stranded target DNA sequence.

7. The method of claim 1 , wherein the one or more nucleotide changes comprise two or more nucleotide insertions, nucleotide substitutions, nucleotide deletions, or a combination of two or more of a nucleotide insertion, a nucleotide substitution, or a nucleotide deletion, as compared to the region of the second strand downstream of the nick site in the double-stranded target DNA sequence.

8. The method of claim 1 , wherein the napDNAbp is a Cas9 nickase (nCas9).

9. The method of claim 8 , wherein the Cas9 nickase is a Cas9 nickase (nCas9) comprising a substitution in the HNH domain.

10. The method of claim 9 , wherein the substitution in the HNH domain is H840A relative to SEQ ID NO: 18.

11. The method of claim 1 , wherein the reverse transcriptase is a retrovirus reverse transcriptase.

12. The method of claim 1 , wherein the reverse transcriptase is a Moloney Murine Leukemia reverse transcriptase (M-MLV RT).

13. The method of claim 1 , wherein the contacting is performed in a cell comprising the double-stranded target DNA sequence, and wherein the contacting results in less than 1% off-target editing in a genome of the cell as measured by sequencing.

14. The method of claim 1 , wherein the contacting is performed in a population of cells each comprising the double-stranded target DNA sequence, and wherein the contacting results in the nucleotide change in at least 1% of the population of cells.

15. The method of claim 1 , wherein the contacting is performed in a population of cells each comprising the double-stranded target DNA sequence, and wherein the contacting results in less than 15% indel frequency as measured by sequencing.

16. The method of claim 1 further comprising contacting the double-stranded target DNA sequence with a guide RNA, wherein the guide RNA directs the napDNAbp to generate a second nick on the first strand of the double-stranded target DNA sequence.

17. The method of claim 16 , wherein the first nick and the second nick are at least 14 nucleotides apart.

18. The method of claim 1 , wherein the one or more nucleotide changes comprise a single nucleotide substitution, a single nucleotide insertion, a single nucleotide deletion, or combinations thereof, as compared to the region of the second strand downstream of the nick site in the double-stranded target DNA sequence.

19. The method of claim 1 , wherein the one or more nucleotide changes are 4-6 bases downstream of the position of the nick site on the second strand in the double-stranded target DNA sequence.

20. The method of claim 1 , wherein the one or more nucleotide changes are at least 7 base pairs downstream of the position of the nick site on the second strand in the double-stranded target DNA sequence, and wherein the DNA synthesis template is at least 12 bases in length.

21. The method of claim 1 , wherein the contacting is performed in a population of cells each comprising the double-stranded target DNA sequence, and wherein the contacting results in the one or more nucleotide changes in at least 20% of the population of cells.

22. The method of claim 1 , wherein the contacting is performed in a population of cells each comprising the double-stranded target DNA sequence, and wherein the contacting results in the one or more nucleotide changes in at least 50% of the population of cells.

23. The method of claim 1 , wherein the contacting is performed in a population of cells each comprising the double-stranded target DNA sequence, and wherein the contacting results in less than 10% indel frequency as measured by sequencing.

24. The method of claim 1 , wherein the contacting is performed in a population of cells each comprising the double-stranded target DNA sequence, and wherein the contacting results in less than 1% indel frequency as measured by sequencing.

25. The method of claim 8 , wherein the nCas9 nickase is derived from a Streptococcus pyogenes Cas9, a Staphylococcus aureus Cas9, a Neisseria meningitis Cas9, a Streptococcus thermophilis Cas9, or a Treponema denticola Cas9.

26. The method of claim 1 , wherein the DNA synthesis template is from 3 nucleotides to 500 nucleotides in length.

27. The method of claim 1 , wherein the DNA synthesis template is from 8 nucleotides to 31 nucleotides in length.

28. The method of claim 1 , wherein the primer binding site is from 3 nucleotides to 500 nucleotides in length.

29. The method of claim 1 , wherein the primer binding site is from 8 nucleotides to 15 nucleotides in length.

30. The method of claim 1 , wherein the spacer sequence is about 20 nucleotides in length.

Assignments (8)
LICENSE Recorded Apr 1, 2025
From: BROAD INSTITUTE, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 070704/0125 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2025
From: ANZALONE, ANDREW VITO
To: THE BROAD INSTITUTE, INC.
Reel/Frame 070222/0708 →
CONFIRMATORY ASSIGNMENT Recorded Feb 14, 2025
From: ANZALONE, ANDREW VITO
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 070236/0384 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2022
From: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
To: THE BROAD INSTITUTE, INC.
Reel/Frame 059156/0175 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2022
From: ANZALONE, ANDREW VITO
To: THE BROAD INSTITUTE, INC.
Reel/Frame 059156/0242 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2022
From: LIU, DAVID R.
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 059310/0887 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2022
From: HOWARD HUGHES MEDICAL INSTITUTE
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 059156/0114 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2022
From: EVERETTE, KELCEE; NEWBY, GREGORY
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 059156/0138 →
Continuity (12)
Continuation PCTUS2020023712 · Mar 19, 2020
Provisional Application 62991069 · Mar 17, 2020
Provisional Application 63100548 · Mar 17, 2020
Provisional Application 62944231 · Dec 5, 2019
Provisional Application 62974537 · Dec 5, 2019
Provisional Application 62931195 · Nov 5, 2019
Provisional Application 62973558 · Oct 10, 2019
Provisional Application 62913553 · Oct 10, 2019
Provisional Application 62922654 · Aug 21, 2019
Provisional Application 62889996 · Aug 21, 2019
Provisional Application 62858958 · Jun 7, 2019
Provisional Application 62820813 · Mar 19, 2019
Cited By (34)
US 12,195,733 US 12,270,029 US 12,281,303 US 12,281,338 US 12,319,938 US 12,331,330 US 12,344,869 US 12,351,814 US 12,351,815 US 12,351,837 US 12,359,218 US 12,390,514 US 12,398,406 US 12,404,525 US 12,406,749 US 12,435,330 US 12,435,331 US 12,454,706 US 12,473,543 US 12,473,573 US 12,509,680 US 12,516,308 US 12,522,807 US 12,544,458 US 12,559,737 US 12,565,666 US 12,570,972 US 12,584,118 US 12,624,353 US 12,624,354 US 12,630,832 US 12,630,833 US 12,668,815 US 12,746,294